As Program Manager, Andrew serves as the liaison between the Collaborative Research Center (CRC) Directors and OMF leadership. He ensures that all parties stay informed on the progress of ongoing OMF funded research projects that support the Foundation’s research agenda.
Andrew is currently Director of Business Development (Clinical Innovation) at Massachusetts General Hospital & Harvard Medical School. He has been affiliated with MGH and Harvard for over 10 years, gaining clinical research and management experience.
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).